PrintNEWS
The life sciences in the news[Please login to post comments]
- Investors Weigh Biotech Results
Podcast: July 26, 2010 Read More - Reckitt Gets Its Mojo Rising
Life sciences deals and financings take a summer break. Read More - Pfizer Halts Trial of Pain Drug
The weekly round-up of failed trials, missed targets and other business mishaps. Read More - Gel is Promising in Preventing HIV Infections
South Africa may put it into use before regulators review it. Read More - Clean Living
Cash rewards with counseling could help prevent STIs. Read More - GAO Study Slams Direct-to-Consumer Genetic Test Companies
Stinging report comes as FDA interest in their products reaches a boil. Read More - Recommendation Reversal
FDA panel says Avastin shouldn’t be marketed for breast cancer. Read More - Mannkind Tries Again
Biopharma resubmits application for inhaled insulin to FDA. Read More - Holding on to the Past
Reprogrammed adult stem cells may not be as versatile as first thought. Read More - European Union Invests in Research and Innovation
Biggest ever funding package aims to stimulate smart growth and jobs. Read More
.gif)
.gif)
- Pfizer's Viagra Weighed by U.S. FDA for Children With Rare Lung Disorder
Bloomberg - New Health Official Faces Hostility in Senate
The New York Times - Pharma seeks FDA clarity on risky drug safeguards
Reuters - Special report: Targeting teens for gastric bands
Reuters - Genzyme Said to Rebuff Sanofi-Aventis Takeover Approach; Genzyme Advances
Bloomberg - Sanofi makes approach to Genzyme -sources
Reuters - Sanofi-Aventis’s Biotech Play for Genzyme
The New York Times - U.S. advisers reject Vivus fat-fighting pill
Reuters - PhRMA Names Business Roundtable's Castellani as CEO, Beginning Sept. 1
Bloomberg - Vivus' fat pill works; safety a concern-FDA staff
Reuters